Effect of VI-0521 (Qsymia®) on Glomerular Filtration Rate (GFR) in Overweight or Obese Healthy Subjects

NCT02229214 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

51

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity

Interventions

DRUG: Qsymia
DRUG: Placebo

Sponsor

VIVUS LLC